←
Craig Wilen1,955 posts
Craig Wilen avatar

Craig Wilen

@WilenLab

Physician-scientist. Dad. Husband. Associate Professor @yaleibio @yale_labmed. We study host-viral interactions #covid #norovirus @wilenlab.bsky.social

◷ Joined May 2011▧ 88 Photos and videos
Gus Hamilton avatar
⟳ Craig Wilen retweeted
Gus Hamilton@gushamilton·Nov 13

This is just the best study I've read all year. Just incredible epi/genetics work. Wow. Also shows always keep your samples! nature.com/articles/s41586-0…

Caleb Lareau avatar
⟳ Craig Wilen retweeted
Caleb Lareau@CalebLareau·Nov 9

Our bodies are colonized by trillions of viruses that we live with in homeostasis. The most diverse and abundant of these viral families are anelloviruses. A new paper from us at @MSKCancerCenter explores what happens after we *all* have been infected biorxiv.org/content/10.64898… 1/n

Director Michael Kratsios avatar
⟳ Craig Wilen retweeted
Director Michael Kratsios@mkratsios47·Nov 5

Today, we released the National Policy for Nucleic Acid Synthesis Screening to protect American biotechnology innovation while reducing the risk of misuse. This policy establishes a new, government-wide screening requirements for synthetic DNA and the equipment used to make it. It will ensure companies selling nucleic acid sequences and synthesis equipment know their customers and prevent the malicious use of these materials and tools. This policy strengthens our Nation’s biosecurity posture by establishing rigorous U.S. government-wide procurement screening and physical security standards for synthetic biology. It replaces outdated “self-attestation” systems with robust, independent verification. It creates a dynamic, SI-powered screening layer that assesses the biological risk from nucleic acid sequences, allowing the U.S. to anticipate and prevent malicious use and help stop dangerous gain-of-function research. @NIST will issue rigorous new screening standards and @HHSGov and @USDA will certify synthetic biology providers. Together, these measures will strengthen American biosecurity, safeguard responsible innovation, and establish a global standard for safe and transparent synthetic biology tools and research.

Post attachment
Craig Wilen avatar
Craig Wilen@WilenLab·Nov 3

Great collaboration with Tongqing Zhou, Danny Douek, Leo Srebryannyy at the NIHVRC @SanghyunLeeLab and led by cofirst authors Zhe Zhao, Paul Tran, Ning Li, Li Ou, and Jaewon Song along with many other key collaborators.

Craig Wilen avatar
Craig Wilen@WilenLab·Nov 3

Together this gives important insight into the molecular basis for parahenipavirus entry, pathogenesis, and host range. This will also enable development of therapeutic antibodies and vaccines.

Craig Wilen avatar
Craig Wilen@WilenLab·Nov 3

We then synthesized EPCRs from diverse animals to gain insight into EPCR host range. Langya could use EPCR from shrews, humans, and select other mammals. This was governed by variation at the Langya-EPCR interface.

Post attachment
Craig Wilen avatar
Craig Wilen@WilenLab·Nov 3

Langya binds to EPCR using a similar mechanism (insertion of a Phe) as EPCR's physiologic ligand Protein C and the malarial parasite protein PfEMP1 highlighting an interesting and unexpected example of convergent evolution

Post attachment
Craig Wilen avatar
Craig Wilen@WilenLab·Nov 3

A 3.1A cryoEM structure shows the EPCR binding epitope is totally different than that of Ephrins on Nipah.

Post attachment
Craig Wilen avatar
Craig Wilen@WilenLab·Nov 3

EPCR also mediates entry of closely related Wenzhou and to a lesser extent Mojiang parahenipaviruses. Mojiang was linked to the deaths of three miners in ~2012.

Post attachment
Craig Wilen avatar
Craig Wilen@WilenLab·Nov 3

We identified EPCR (encoded by PROCR) in a CRISPRa screen and then validated it as a receptor using pseudoviruses

Post attachment